Slovakia’s distributed ledger tech (DLT) healthcare startup Hilbi will be acquiring substantial investments from a highly-experienced healthcare visionary. A top executive from a major international pharmaceutical giant will be joining Hilbi’s team. Daren Wilson will take part in the firm’s new €5 million investment round.
Hilbi is an artificial intelligence (AI)-based, decentralized communication system that can be used to make instant payments. Hilbi’s software has been designed to protect patients during their healing process.
Daren Wilson, a senior executive at a multinational pharmaceutical company, will be holding 12% (€600,000) of the total sum of €5 million being invested into Hilbi’s business operations.
One powerful, seamless app to support the entire healthcare system
In response to a question regarding Hilbi’s main value proposition, Wilson noted: “There are thousands of digital health apps across multiple diseases. Now, imagine if there was just one app to support the entire ecosystem around the patient. Hilbi has this potential. Their business model is different as they add more value and trust towards physician-patient relationships so that the patient can benefit from the highest quality of care from their health professionals.”
Elaborating on what appealed to him about Hilbi, Wilson stated: “When you are looking at interesting investment opportunities, the passion and commitment of the founders are important. I saw this in Patrik Kmeč, who has a noble vision for the future of personalised patient care.”
Hilbi offers a one-of-a-kind ecosystem, in which a patient owns their healthcare data. The platform securely gathers all information using decentralized ledger technology, and then shares it with the professionals who are part of the network. Hilbi’s health profile, called LifeID, is a useful tool for making a diagnosis, providing treatment, and appropriate prevention recommendations. Artificial intelligence (AI)-powered algorithms will be used to help protect patients not only during their healing process but also during prevention and in the event of an accident.
Roman Kučera, CEO at 01People and co-founder of Hilbi’s technology, explained how the platform can share vital patient health data: “There’s an exchange of structural information with added value to it. We are trying to save doctors a lot of time to identify the problem with an automatic substitution for now, and later with artificial intelligence. We are aiming globally, and therefore people can use it anywhere in the world with an internet connection.”
Daren Wilson, an executive at a leading pharmaceutical company, has extensive experience in the medical industry. He’s helped many companies from across the globe and will now join Hilbi as a private investor.
When questioned about why he invested in Hilbi’s business operations, Wilson said: “Hilbi is a Slovak digital healthcare company with a high potential to scale, globally. I decided to invest in Hilbi because they align to my personal values and their bold vision is to support the personal healthcare needs of every person in society.”
A software platform as large and useful as Facebook, WhatsApp or Uber
He believes that Hilbi has a lot of potential to offer personal healthcare services to patients around the world in the area of instant payments.
Patrik Kmeč, co-founder at Hilbi, remarked: “Daren is a well-experienced person in the area of global solutions for digitizing healthcare. As a smart investor, his experience will help the Hilbi team in further refining their industry leading products. In Slovakia, we are developing a platform that can serve a large number of users like WhatsApp, Facebook, or Uber. Our platform will be purpose-built for doctor’s and patient’s specific healthcare needs. You need an internationally experienced team for this kind of project.”
Kmeč further noted: “I’m extremely happy that our first investor is such a knowledgeable professional. It brings great opportunities for other investors, as Hilbi’s software is deployed and monetized on the world’s largest markets including the US and third-world countries.”
Most of Hilbi’s returns will be distributed to physicians and healthcare providers
One of Hilbi’s primary value propositions is its unique compensation system, which transparently divides platform revenue based on the work done by each healthcare provider. Hilbi users can conveniently make payments using their debit cards or their bank accounts. When a patient wants to pay for services, the healthcare provider is able to receive the payment directly into their account.
Dr. Pásztor believes Hilbi is an excellent product for diabetic patients. The program can also assist patients during an oncological treatment, and those who may be receiving orthopedic care.
The Hilbi team members are planning to launch its first AI-powered algorithm this year, which will be used to identify the initial symptoms of cardiovascular disease.
Contact for media: TIME.is COMMUNICATION, [email protected]eu, +421-907-821016.